Malaysia Semiconductor Industry Eyes Helium Supply Risks Amid Middle East Conflict 
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production 
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield 
Micron Technology Beats Q2 Earnings Estimates, Issues Strong AI-Driven Outlook 
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco 
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency 
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push 
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion 
9 Tips for Avoiding Tax Season Cyber Scams 
Elon Musk Announces Terafab: SpaceX and Tesla to Build Dual AI Chip Factories in Austin, Texas 
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push 
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion 
Super Micro Computer Shares Plunge After Co-Founder Charged in AI Chip Smuggling Case 
Amazon's "Transformer" Phone: Can It Succeed Where Fire Phone Failed? 
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push 
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations 
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation 
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
